LEH Pharma Appoints Syneos Health as Global Clinical Development and Commercialisation Solutions Provider LEH Pharma Ltd(“LEH Pharma” or the “Company”) LEH Pharma Appoints Syneos Health as Global Clinical Development and Commercialisation Solutions Provider London, UK – 22 October 2018 -- LEH...

LEH Pharma Appoints Syneos Health as Global Clinical Development and Commercialisation Solutions Provider LEH Pharma Ltd(“LEH Pharma” or the “Company”) LEH Pharma Appoints Syneos Health as Global Clinical Development and Commercialisation Solutions Provider London, UK – 22 October 2018 -- LEH Pharma...

LEH Pharma announces first EyeMax Mono surgery performed in South Africa LEH Pharma Ltd(“LEH Pharma” or the “Company”) LEH Pharma announces first EyeMax Mono surgery performed in South Africa Successful lens implantation for both eyes performed in Western Cape,...

LEH Pharma announces first EyeMax Mono surgery performed in Argentina LEH Pharma Ltd(“LEH Pharma” or the “Company”) LEH Pharma announces first EyeMax Mono surgery performed in Argentina EyeMax now available in over 25 countries worldwideArgentina represents...

LEH Pharma appoints two new members to its Scientific Advisory Board LEH Pharma Ltd(“LEH Pharma” or the “Company”) LEH Pharma appoints two new members to its Scientific Advisory Board London, UK – 13 June 2018 -- LEH Pharma Ltd, the leading provider of novel ocular...